Disagree
Home Substances
Ambroxol

Ambroxol

A-Z
Search for:
Substance Overview and History

Ambroxol is a mucolytic agent widely used to manage respiratory conditions such as chronic bronchitis, COPD, and asthma. It works by reducing mucus viscosity and stimulating surfactant production, improving mucociliary clearance. This helps clear airways, alleviating symptoms like persistent cough and breathing difficulty. Additionally, ambroxol has anti-inflammatory and antioxidant effects, reducing respiratory tract inflammation and oxidative stress. It’s available in various forms, including tablets and syrups, offering flexibility in treatment.

References:

Magalhaes, J., Gegg, M.E., Migdalska-Richards, A. and Schapira, A.H., 2018. Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ
What is ambroxol used for?
Ambroxol is used to treat respiratory conditions such as chronic bronchitis, COPD, and asthma by breaking down thick mucus and facilitating its expulsion.
References:

Magalhaes, J., Gegg, M.E., Migdalska-Richards, A. and Schapira, A.H., 2018. Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports.

How does ambroxol work?
It reduces mucus viscosity, stimulates surfactant production, and enhances ciliary movement, improving mucociliary clearance.
References:

Magalhaes, J., Gegg, M.E., Migdalska-Richards, A. and Schapira, A.H., 2018. Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports.

What forms is ambroxol available in?
Ambroxol is available in tablets, syrups, lozenges, and inhalation solutions, allowing flexible administration for various patient needs.
References:

Magalhaes, J., Gegg, M.E., Migdalska-Richards, A. and Schapira, A.H., 2018. Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports.